<SEC-DOCUMENT>0001558370-22-010491.txt : 20220630
<SEC-HEADER>0001558370-22-010491.hdr.sgml : 20220630
<ACCEPTANCE-DATETIME>20220630171011
ACCESSION NUMBER:		0001558370-22-010491
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20220629
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220630
DATE AS OF CHANGE:		20220630

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Protalix BioTherapeutics, Inc.
		CENTRAL INDEX KEY:			0001006281
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				650643773
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33357
		FILM NUMBER:		221058714

	BUSINESS ADDRESS:	
		STREET 1:		2 UNIVERSITY PLAZA
		STREET 2:		SUITE 100
		CITY:			HACKENSACK
		STATE:			NJ
		ZIP:			07601
		BUSINESS PHONE:		201-696-9345

	MAIL ADDRESS:	
		STREET 1:		2 UNIVERSITY PLAZA
		STREET 2:		SUITE 100
		CITY:			HACKENSACK
		STATE:			NJ
		ZIP:			07601

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ORTHODONTIX INC
		DATE OF NAME CHANGE:	19980422

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EMBASSY ACQUISITION CORP
		DATE OF NAME CHANGE:	19960124
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>plx-20220629x8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='UTF-8'?>

      <!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 9.6.8119.21675 -->
      <!-- Based on: iXBRL 1.1 -->
      <!-- Created on: 6/30/2022 8:41:57 PM -->
      <!-- iXBRL Library version: 1.0.8119.21683 -->
      <!-- iXBRL Service Job ID: 187409b9-b801-478a-bc9b-5a5ea1ead126 -->

  <html xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns="http://www.w3.org/1999/xhtml" xmlns:plx="http://protalix.com/20220629" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html" /><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg" name="dei:EntityCentralIndexKey" id="Tc__Yj22le_BUegyw6X7dj_RQ_2_1">0001006281</ix:nonNumeric><ix:nonNumeric contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg" name="dei:AmendmentFlag" id="Tc_xT_Rm3hJ5kSCd_lo8HvBug_3_1">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="plx-20220629.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001006281</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-29</xbrli:startDate><xbrli:endDate>2022-06-29</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;min-height:13.8pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1pt;padding-bottom:1pt;padding-top:1pt;text-align:center;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:3pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_0e9ca0c2_ebd9_4bd2_825b_93ebacf24761"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 4pt 0pt;"><b style="font-weight:bold;">Washington, D.C. 20549</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:12.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">FORM&#160;</b><ix:nonNumeric contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg" name="dei:DocumentType" id="Narr_1W7FGdRXS0aT_Abpo1tvJA"><b style="font-weight:bold;">8-K</b></ix:nonNumeric></p><div style="font-family:'Times New Roman','Times','serif';font-size:12.0pt;margin-bottom:4pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CURRENT REPORT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pursuant to Section&#160;13 or 15(d)&#160;of</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">the Securities Exchange Act of 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 4pt 0pt;"><b style="font-weight:bold;">Date of Report (Date of Earliest Event Reported): </b><ix:nonNumeric contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="Narr_qLZDCZoOLE6-2mkJUSdMeQ"><b style="font-weight:bold;">June&#160;29, 2022</b></ix:nonNumeric></p><div style="font-family:'Times New Roman','Times','serif';font-size:12.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg" name="dei:EntityRegistrantName" id="Narr_MUUPBGJ8pU-9e0KOAp7UXg"><b style="font-weight:bold;">Protalix BioTherapeutics,&#160;Inc.</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Exact name of registrant as specified in its charter)</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:12.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_db44e2d3_a4d8_4690_a9da_b28605fc200d"></a><a id="Tc_qxQQ-UgeGkSHeh62hdklnA_2_0"></a><a id="Tc_JN5tvCGGZ0OlQx6dviRYpw_2_2"></a><a id="Tc_qOsrjPumrEi2WoQqoLDW8A_2_4"></a><a id="Tc_8LmZ106jwE2OLzfVJu8tFg_6_0"></a><a id="Tc_eLJHMi2xYU202HoIcB1ajw_7_0"></a><a id="Tc_9w-SfDoFz0eh1HvJXRsnJQ_7_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:34.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:25.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:34.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:34.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="Tc_CA84kJMf0kqwPT-wjJQG4g_1_0"><b style="font-weight:bold;">Delaware</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:25.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg" name="dei:EntityFileNumber" id="Tc_dEbe0TfPg0Sg8Hs2sloUyQ_1_2"><b style="font-weight:bold;">001-33357</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:34.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg" name="dei:EntityTaxIdentificationNumber" id="Tc_Nl-g9ajxPkepSU6oZyT0kQ_1_4"><b style="font-weight:bold;">65-0643773</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:34.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(State or other jurisdiction</b><br /><b style="font-weight:bold;">of incorporation)</b></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:25.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Commission File Number)</b></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:34.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(IRS Employer</b><b style="font-weight:bold;"><br /></b><b style="font-weight:bold;">Identification No.)</b></p></td></tr><tr><td style="vertical-align:bottom;width:34.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:25.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:34.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:34.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg" name="dei:EntityAddressAddressLine1" id="Tc_t7nSyw6twkquMb7bU8WWZA_4_0"><b style="font-weight:bold;">2 University Plaza</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:25.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:34.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:34.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg" name="dei:EntityAddressAddressLine2" id="Tc_WAKgzDpNSEmoGVS8X329mg_5_0"><b style="font-weight:bold;">Suite 100</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:25.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:34.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:34.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg" name="dei:EntityAddressCityOrTown" id="Narr_PQ9n9lw3LU2FzCOZZvmkDQ"><b style="font-weight:bold;">Hackensack</b></ix:nonNumeric><b style="font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg" name="dei:EntityAddressStateOrProvince" id="Narr_QL8QrMygXk2Lx7l-rUQRSw"><b style="font-weight:bold;">NJ</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:25.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:34.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg" name="dei:EntityAddressPostalZipCode" id="Tc_d8ZYb8g62ECfUMEsaI6vCw_6_4"><b style="font-weight:bold;">07601</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:34.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Address of principal executive offices)</b></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:25.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:34.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Zip Code)</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 10pt 0pt;">&#160;<b style="font-weight:bold;">Registrant&#8217;s telephone number, including area code </b><ix:nonNumeric contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg" name="dei:CityAreaCode" id="Narr_FO8gwj9XgUyaUtsymSwdyg"><b style="font-weight:bold;">201</b></ix:nonNumeric><b style="font-weight:bold;">-</b><ix:nonNumeric contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg" name="dei:LocalPhoneNumber" id="Narr_bOQGoZ7wNkuc9wH5CEkWzA"><b style="font-weight:bold;">696-9345</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Former name or former address, if changed since last report.)</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:12.0pt;margin-bottom:10pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i style="font-style:italic;">see</i> General Instruction A.2. below):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><ix:nonNumeric contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Narr_9oAL9kf_OUGtCuF8BiWhaQ"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric>&#160;&#160;&#160;&#160;Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><ix:nonNumeric contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Narr_siaT9q8PZUCy6jndT-dvIw"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric>&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><ix:nonNumeric contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Narr_K5ps0hLs10GyP_44f_6-rg"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric>&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Narr_W-3meAowz0OzE3lcnC0R2A"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric>&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_e77e804a_d223_4729_927d_c6bf13fbe4e3"></a><a id="Tc_txTK9Fr5MUG_YS7tcGRnlQ_1_0"></a><a id="Tc_BjdbdVUDbEafX4Byu9niYA_1_1"></a><a id="Tc_0T5pgPW0QEG0LfbvkglJcA_1_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:40%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:19.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:39.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:40%;border-bottom:1.0pt solid #000000;border-left:1.0pt solid #000000;border-right:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 4.9pt 0pt 4.9pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Title of each class</p></td><td style="vertical-align:bottom;width:19.99%;border-bottom:1.0pt solid #000000;border-right:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 4.9pt 0pt 4.9pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Trading Symbol(s)</p></td><td style="vertical-align:bottom;width:39.99%;border-bottom:1.0pt solid #000000;border-right:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 4.9pt 0pt 4.9pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Name of each exchange on which registered</p></td></tr><tr><td style="vertical-align:top;width:40%;border-bottom:1.0pt solid #000000;border-left:1.0pt solid #000000;border-right:1.0pt solid #000000;margin:0pt;padding:0pt 4.9pt 0pt 4.9pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg" name="dei:Security12bTitle" id="Tc_aW3-ssdNBE6PWV9sgN6lLw_2_0">Common stock, $0.001 par value</ix:nonNumeric></p></td><td style="vertical-align:top;width:19.99%;border-bottom:1.0pt solid #000000;border-right:1.0pt solid #000000;margin:0pt;padding:0pt 4.9pt 0pt 4.9pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg" name="dei:TradingSymbol" id="Tc_f-j9iEEAlUOcuYzFxJbtDA_2_1">PLX</ix:nonNumeric></p></td><td style="vertical-align:top;width:39.99%;border-bottom:1.0pt solid #000000;border-right:1.0pt solid #000000;margin:0pt;padding:0pt 4.9pt 0pt 4.9pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="Tc_3CqIg8mhREKkATw7m76Qxg_2_2">NYSE American</ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule&#160;12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 10pt 0pt;">Emerging growth company <ix:nonNumeric contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_lmGOFGRG3EutpwYxjUYdcg"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act. <span style="font-family:Times New Roman;">&#9723;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:3pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1pt;padding-bottom:1pt;padding-top:1pt;border-bottom:3.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:72pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin-bottom:10pt;margin-top:0pt;">Item&#160;5.02</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin-bottom:10pt;margin-top:0pt;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers</p></td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:11.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:88.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</span></span>On June&#160;29, 2022, the Board of Directors of Protalix BioTherapeutics, Inc. (the &#8220;Company&#8221;) appointed Shmuel Ben&#160;Zvi, Ph.D. to serve on the Company&#8217;s Board of Directors, effective as of the adjournment of the Company&#8217;s 2022 Annual Meeting of Stockholders held on June&#160;30, 2022 (the &#8220;Meeting&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;margin:0pt;">Dr.&#160;Ben Zvi will be entitled to the standard compensation amounts payable to non-employee directors of the Board of Directors and will enter into the Company&#8217;s standard form of officers&#8217; and directors&#8217; indemnification agreements pursuant to which the Company agrees to indemnify its officers and directors to the fullest extent permitted by applicable law and, subject to certain conditions, to advance expenses in connection with proceedings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:10pt;background:#ffffff;margin:0pt;">There are no arrangements or understandings between Dr.&#160;Ben&#160;Zvi and any other persons pursuant to which Dr.&#160;Ben&#160;Zvi was appointed to the Board of Directors. There are no relationships or related transactions between Dr.&#160;Ben Zvi and the Company that would be required to be reported.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt 0pt 10pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</span></span>The Company&#8217;s Board of Directors previously approved, subject to stockholder approval, certain amendments to the Company&#8217;s 2006 Stock Incentive Plan, as amended, to increase the number of shares of common stock available under the plan and to amend certain other terms of said plan (the &#8220;Plan&#8221;). As described below under Item 5.07, the Company&#8217;s stockholders approved the amendments to the Plan at the Meeting. The amendments to the Plan became effective upon stockholder approval and, among other changes, increased the number of shares of common stock available under the Plan from 5,725,171 shares to 8,475,171 shares, as described in Proposal 3 of the Company&#8217;s definitive proxy statement filed on Schedule 14A with the U.S.&#160;Securities and Exchange Commission on April&#160;29, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:72pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item&#160;5.07</b></span>Submission of Matters to a Vote of Security Holders</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:11.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:88.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Meeting was held on June&#160;30, 2022. At the Meeting, the Company&#8217;s stockholders: (1)&#160;elected the six persons nominated by the Company&#8217;s Board of Directors to serve as directors of the Company; (2)&#160;approved, on a non-binding, advisory basis, the compensation of the Company&#8217;s named executive officers; (3)&#160;adopted amendments to the Protalix BioTherapeutics,&#160;Inc. 2006 Stock Incentive Plan, as amended, to increase the number of shares of common stock available under the plan from 5,725,171 shares to 8,475,171 shares and to amend certain other terms of said plan; (4)&#160;approved an amendment to the Company&#8217;s Certificate of Incorporation, as amended, to increase the number of shares of its common stock authorized for issuance from 120,000,000 to 144,000,000; and (5)&#160;ratified the appointment of Kesselman &amp; Kesselman, Certified Public Accountant (Isr.), a Member of PricewaterhouseCoopers International Limited, as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December&#160;31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;">Set forth below, with respect to each such proposal, are the number of votes cast for or against or withheld, as applicable, the number of abstentions and the number of broker non-votes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(1)</span></span>Election of Directors</p><div style="padding-left:33.75pt;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:84.28%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.77%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:21.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:23.16%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:21.25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr style="height:23.55pt;"><td style="vertical-align:top;width:33.77%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td><td style="vertical-align:top;width:21.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-line:none;"><span style="display:inline-block;visibility:hidden;width:0pt;">&#8203;</span><br /></b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">For</b></p></td><td style="vertical-align:top;width:23.16%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-line:none;"><span style="display:inline-block;visibility:hidden;width:0pt;">&#8203;</span><br /></b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Withheld</b></p></td><td style="vertical-align:top;width:21.25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Broker</b><b style="font-weight:bold;text-decoration-line:none;"><br /></b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Non-Votes</b></p></td></tr><tr><td style="vertical-align:top;width:33.77%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Zeev Bronfeld</p></td><td style="vertical-align:bottom;width:21.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">17,628,275</p></td><td style="vertical-align:bottom;width:23.16%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">3,010,165</p></td><td style="vertical-align:bottom;width:21.25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">7,139,061</p></td></tr><tr><td style="vertical-align:top;width:33.77%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dror Bashan</p></td><td style="vertical-align:bottom;width:21.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">19,650,379</p></td><td style="vertical-align:bottom;width:23.16%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">988,061</p></td><td style="vertical-align:bottom;width:21.25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">7,139,061</p></td></tr><tr><td style="vertical-align:top;width:33.77%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Amos Bar Shalev</p></td><td style="vertical-align:bottom;width:21.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">18,629,151</p></td><td style="vertical-align:bottom;width:23.16%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">2,009,289</p></td><td style="vertical-align:bottom;width:21.25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">7,139,061</p></td></tr><tr><td style="vertical-align:top;width:33.77%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Pol F. Boudes, M.D.</p></td><td style="vertical-align:bottom;width:21.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">19,922,942</p></td><td style="vertical-align:bottom;width:23.16%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">715,498</p></td><td style="vertical-align:bottom;width:21.25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">7,139,061</p></td></tr><tr><td style="vertical-align:top;width:33.77%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gwen A. Melincoff</p></td><td style="vertical-align:bottom;width:21.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">19,811,503</p></td><td style="vertical-align:bottom;width:23.16%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">826,937</p></td><td style="vertical-align:bottom;width:21.25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">7,139,061</p></td></tr><tr><td style="vertical-align:top;width:33.77%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Aharon Schwartz, Ph.D.</p></td><td style="vertical-align:bottom;width:21.8%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">18,229,486</p></td><td style="vertical-align:bottom;width:23.16%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">2,408,954</p></td><td style="vertical-align:bottom;width:21.25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">7,139,061</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(2)</span></span>Approval, on a non-binding, advisory basis, the compensation of the Company&#8217;s named executive officers</p><div style="padding-left:40.85pt;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:78.13%;"><tr><td style="vertical-align:top;width:25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-line:none;"><span style="display:inline-block;visibility:hidden;width:0pt;">&#8203;</span><br /></b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">For</b></p></td><td style="vertical-align:top;width:25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-line:none;"><span style="display:inline-block;visibility:hidden;width:0pt;">&#8203;</span><br /></b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Against</b></p></td><td style="vertical-align:top;width:25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-line:none;"><span style="display:inline-block;visibility:hidden;width:0pt;">&#8203;</span><br /></b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Abstain</b></p></td><td style="vertical-align:top;width:25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Broker</b><b style="font-weight:bold;text-decoration-line:none;"><br /></b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Non-Votes</b></p></td></tr><tr style="height:8.1pt;"><td style="vertical-align:bottom;width:25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">16,953,326</p></td><td style="vertical-align:bottom;width:25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">3,466,524</p></td><td style="vertical-align:bottom;width:25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">218,590</p></td><td style="vertical-align:bottom;width:25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">7,139,061</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(3)</span></span>Adoption of amendments to the Protalix BioTherapeutics,&#160;Inc. 2006 Stock Incentive Plan, as amended, to increase the number of shares of common stock available under the plan from 5,725,171 shares to 8,475,171 shares and to amend certain other terms of said plan</p><div style="padding-left:40.85pt;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:78.13%;"><tr style="height:1pt;"><td style="vertical-align:top;width:25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-line:none;"><span style="display:inline-block;visibility:hidden;width:0pt;">&#8203;</span><br /></b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">For</b></p></td><td style="vertical-align:top;width:25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-line:none;"><span style="display:inline-block;visibility:hidden;width:0pt;">&#8203;</span><br /></b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Against</b></p></td><td style="vertical-align:top;width:25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-line:none;"><span style="display:inline-block;visibility:hidden;width:0pt;">&#8203;</span><br /></b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Abstain</b></p></td><td style="vertical-align:top;width:25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Broker</b><b style="font-weight:bold;text-decoration-line:none;"><br /></b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Non-Votes</b></p></td></tr><tr style="height:4pt;"><td style="vertical-align:bottom;width:25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">18,082,274</p></td><td style="vertical-align:bottom;width:25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">2,383,733</p></td><td style="vertical-align:bottom;width:25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">172,433</p></td><td style="vertical-align:bottom;width:25%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">7,139,061</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(4)</span></span>Approval of an amendment to the Company&#8217;s Certificate of Incorporation, as amended, to increase the number of shares of its common stock authorized for issuance from 120,000,000 to 144,000,000</p><div style="padding-left:40.85pt;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:58.6%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">For</b></p></td><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Against</b></p></td><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Abstain</b></p></td></tr><tr style="height:7.65pt;"><td style="vertical-align:bottom;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">24,916,349</p></td><td style="vertical-align:bottom;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">2,673,571</p></td><td style="vertical-align:bottom;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">187,581</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(5)</span></span>Ratification of the appointment of Kesselman &amp; Kesselman</p><div style="padding-left:40.85pt;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:58.6%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">For</b></p></td><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Against</b></p></td><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Abstain</b></p></td></tr><tr style="height:7.65pt;"><td style="vertical-align:bottom;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">27,053,102</p></td><td style="vertical-align:bottom;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">577,241</p></td><td style="vertical-align:bottom;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">147,158</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:72pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item&#160;8.01</b></span>Other Events</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">On June&#160;30, 2022, the Company issued a press release announcing the appointment of Dr.&#160;Ben&#160;Zvi to the Board of Directors. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:72pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item&#160;9.01</b></span>Financial Statements and Exhibits</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:12.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:0.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:86.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:12.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exhibit No.</p></td><td style="vertical-align:bottom;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:86.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Description</p></td></tr><tr><td style="vertical-align:top;width:12.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:86.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:top;width:12.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">99.1</p></td><td style="vertical-align:bottom;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:86.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="plx-20220629xex99d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Press Release dated June&#160;30, 2022</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">104</p></td><td style="vertical-align:bottom;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:86.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</p></td></tr><tr><td style="vertical-align:top;width:12.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:86.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">SIGNATURES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:56.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:6.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:33.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:56.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: June&#160;30, 2022</p></td><td colspan="3" style="vertical-align:top;width:43.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">PROTALIX BIOTHERAPEUTICS,&#160;INC.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:56.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:6.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:33.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:top;width:56.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="2" style="vertical-align:top;width:40.02%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Eyal Rubin</p></td></tr><tr><td style="vertical-align:top;width:56.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:6.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:33.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Eyal Rubin</p></td></tr><tr><td style="vertical-align:top;width:56.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:3.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:6.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:33.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sr. Vice President and Chief Financial Officer</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>plx-20220629xex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 6/30/2022 08:42:35 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:12.09%;padding-right:12.09%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">Exhibit 99.1</b></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><img src="plx-20220629xex99d1001.jpg" alt="Graphic" style="display:inline-block;height:39.15pt;width:128.45pt;"></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Protalix BioTherapeutics Appoints Shmuel &#8220;Muli&#8221; Ben Zvi, Ph.D.</b><b style="font-weight:bold;"><br></b><b style="font-weight:bold;">to its Board of Directors</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;background:#ffffff;margin:0pt 4.5pt 12pt 0pt;">Carmiel, Israel, June&#160;30, 2022 /PRNewswire / Protalix BioTherapeutics, Inc. (NYSE American:PLX, TASE:PLX), announced today that the Company&#8217;s Board of Directors has appointed Shmuel &#8220;Muli&#8221; Ben&#160;Zvi, Ph.D. to serve on the Company&#8217;s Board of Directors. In addition to Dr. Ben Zvi&#8217;s appointment as an independent director, he was also appointed to serve on the Company&#8217;s Audit Committee and Compensation Committee.</p><div style="margin-left:0pt;" align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:100%;"><tr><td style="vertical-align:top;width:49.77%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;padding-bottom:12pt;background:#ffffff;margin:0pt 4.5pt 0pt 0pt;">&#8220;We are excited to have Muli join our Board of Directors,&#8221; commented Zeev Bronfeld, Chairman of Protalix&#8217;s Board of Directors. &#8220;He brings extensive financial and economic knowledge, as well as vast management, business and auditing experience, which will be a valuable contribution to our Board of Directors as Protalix continues to execute its strategic plan.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;background:#ffffff;margin:0pt 4.5pt 12pt 0pt;">Dr. Ben&#160;Zvi currently serves on the Board of Directors of Bank Leumi, and serves on the credit, technology and strategy committees thereof. He also serves on the Board of Directors of Sol-Gel Technologies Ltd., where he is a member of the audit and compensation committees, and on the Board of Directors of Vascular Biogenics Ltd., where he also serves on the audit and compensation committees.</p></td><td style="vertical-align:top;width:50.22%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 4.3pt 12pt 0pt;"><img src="plx-20220629xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:216pt;width:211.5pt;"></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 4.3pt 12pt 0pt;"><i style="font-style:italic;">Shmuel Ben Zvi, Ph.D., Director, Protalix BioTherapeutics, Inc. (photo by Shani Nachmias)</i></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 12pt 0pt;">From 2004 to 2014, Dr. Ben&#160;Zvi serviced in a number of managerial positions at Teva Pharmaceuticals Industries Ltd., the last two being Vice President, Strategy and Vice President, Finance. From 2000 to 2004, Dr. Ben&#160;Zvi was the financial advisor to the chief of general staff of the Israel Defense Forces and head of the Defense Ministry budget department. Dr. Ben&#160;Zvi holds a B.A. and an M.A., both Cum Laude, and a Ph.D. in economics, all from Tel-Aviv University, Israel. He also participated in the Harvard Business School Advanced Management Program (AMP) and in National Security &amp; Political Science programs at the National Security College, Israel and Haifa University, Israel. Dr. Ben&#160;Zvi performed post doctoral studies in Economics at the Massachusetts Institute of Technology.</p><p style="color:#373737;font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="color:#000000;font-weight:bold;">About Protalix BioTherapeutics, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;">Protalix is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx. Protalix was the first company to gain U.S.&#160;Food and Drug Administration (FDA) approval of a protein produced through plant cell-based in suspension </p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:12.09%;margin-right:12.09%;margin-top:30pt;page-break-after:always;width:75.81%;border-width:0;"><div style="max-width:100%;padding-left:12.09%;padding-right:12.09%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 12pt 0pt;">expression system. Protalix&#8217;s unique expression system represents a new method for developing recombinant proteins in an industrial-scale manner.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 12pt 0pt;">Protalix&#8217;s first product manufactured by ProCellEx, taliglucerase alfa, was approved by the FDA in May 2012 and, subsequently, by the regulatory authorities of other countries. Protalix has licensed to Pfizer Inc. the worldwide development and commercialization rights for taliglucerase alfa, excluding Brazil, where Protalix retains full rights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 12pt 0pt;">Protalix&#8217;s development pipeline consists of proprietary versions of recombinant therapeutic proteins that target established pharmaceutical markets, including the following product candidates: pegunigalsidase alfa, a modified stabilized version of the recombinant human &#945;-Galactosidase-A protein for the treatment of Fabry disease; alidornase alfa or PRX-110, for the treatment of various human respiratory diseases or conditions; PRX-115, a plant cell-expressed recombinant PEGylated uricase for the treatment of severe gout; PRX-119, a plant cell-expressed long action DNase&#160;I for the treatment of NETs-related diseases; and others. Protalix has partnered with Chiesi Farmaceutici S.p.A., both in the United States and outside the United States, for the development and commercialization of pegunigalsidase alfa.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Forward-Looking Statements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 12pt 0pt;">To the extent that statements in this press release are not strictly historical, all such statements are forward-looking, and are made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. The terms &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;should&#8221; and &#8220;intend,&#8221; and other words or phrases of similar import are intended to identify forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. These statements are based on our current beliefs and expectations as to such future outcomes. Drug discovery and development involve a high degree of risk, and various factors may cause differences between our expectations and actual results as discussed in greater detail in our filings with the Securities and Exchange Commission. The statements in this press release are valid only as of the date hereof and we disclaim any obligation to update this information, except as may be required by law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Investor Contact</b><br>Chuck Padala, Managing Director<br>LifeSci Advisors<br>646-627-8390<br>chuck@lifesciadvisors.com</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:12.09%;margin-right:12.09%;margin-top:30pt;page-break-after:avoid;width:75.81%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>plx-20220629xex99d1001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 plx-20220629xex99d1001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  T *L# 2(  A$! Q$!_\0
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M@F]^R5;Q^,?C5\<?'FH#SM6&O-HELTG+6]M%G"#T!"Q_]\4 :=C^S7\4O%L
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M?Q;^)-AK2C9+X8FU>;^UDN/^> MA'O9\\# *GKG'- 'L?CG]HO1/"GPO\/\
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M+6[^(/@+_A&_#=S-' VM:=JJ:A%8L[!4^U*$1D0L0#(NY02,X'-=-\1?BO\
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M,#% ';A%!S@9]<4AB4G)Y-%% "3V\=S$T4J++&PPR. P/U!IT<:Q(J(H1%&
MJC  HHH  @!) Y/6@(%! XS110 *@4\<5&;2$W G,2>>!M$NT;@/3/6BB@"1
MD#')YHV\#KQ110!%%9P0&0Q0QQ&0Y<H@&X^_K7D7CQ0O[37PF Z#2M<_]!M:
M** /7H+."V+F&)(BYR_EJ%W'U..M2LH=2K %2,$'O110!';VT5I&(X(DAC'.
MR-0H_(47%K%=QF.:-)8SU210P/X&BB@!ZQJF-H P,# Z#TH$:KNP.&ZBBB@
M"!5P.![5%%900-(T4,<32'+E%"EC[XZT44 /EMXY]OF1K)M.1N4'!]>:>!@4
%44 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>plx-20220629xex99d1002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 plx-20220629xex99d1002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &P :<# 2(  A$! Q$!_\0
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M;7OU/. 5&0:LZ;X_T/5<""_B+$XVEL&E=!8Z,4M11W$4@!5U8'I@U,.E,04
M4H&>:7% "8I"*?BDH 9BEQ2XHQF@!N,4AIY&::10!&1BDQ4A%-(H 9BD(YI^
M*2@!A%(13S330,C85&14S"F$4 1D5&RU,1BFL,T 5RM,85.5IC+0.Q5=:C9:
MLLIJ)ES286*Q%,9:G9*8PI!8K.**D=:*!C%6I57BA4J4+0 *M2JM-5>:F5:
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M43+5AAS43"D!79:B9>:LNM1,*0%9Q13W%% "A:D"T 4\#I0 *M3 4U5J4#%
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M_D,8MY^'4<;NOZUT&*YUM.-E=F9ODD8_,NXD@?GQ701,'C5AD@CO7N4I\R/
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M7HH L 4\"D44\=*  "G**!3@* % IX%(!3A0 "G 4E** '"G"D!IPH <*7%
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MC)DKNZ*:[*?4(UBW8 SGC/-<?K=T)$)"@YR#CM6%5I;&M.[W1Y)XWNEN;BW
M/))_2NEO[:._T+02D6Z<!45P><>E<AKD+2:F^[HA(7%>C>'=%=-*21[J228+
ME$(&V-?0>]8QVL=<'RR4^PX;I=0<;LQQ*L8P.#@<_K5T"J]MA<(JX SDU9KZ
M7 QM2N?,YK+FQ%ET2#%)2FDKO/& TG2EX%(30 PTW%.:FXR*!C31WI2*2D,:
M:8W%//%,8T@(V-0FIFJ(T -Z4TFG&F&@!":B?O4A-1/0!$U1/4C5&>M $1XH
MH:B@"R*4'%)10 \#-.'%,4\T\&@!XIPIHIRT . XI:3.* : '4]34>:<IH D
MIRBFT\4 *#2BF]*=3 <*<.348-/% #B.*X'XSZ,NK>";G<H8PD.,]NU=]6?X
M@TL:UHM[8G ,\10$],]JB<>>#B;49^SJ1GV9\4?V+%X@M9H;K=Y]MC9,J@L"
M#\IS5[1F^SW<BL!D-@YK?U6Q.@ZK-9S*;.XC?$L<HYSV/T/:N>AC-Q?7(C?>
M220PKYYW5TSZRK9M2CL?2OPWUM18PJ<  =<UZ/\ V_$D31EL,1D/Z5\N^$O%
M,VGZ2[L&_=#&">IKL+#Q%J-W:I+< 0J1G'M7$TT]#>+BTKESXF^+HH;U8?,#
MJ3E_2JGPWU"WN]1+Q2#)&<9Z<^E<OXELXM15\_,#GDGK7F>FKJO@?7$O]*GG
MFCWY\F5\A>>5&>WM793AS1LB95.1\W0^^=$@AOE=UEPR@'MFL+Q#<PVLQ:25
M00<XZ5X7X-^-&N2Z@ROI;A6& 2V,$UV-W\/I?'#_ &[5[BZ:'[ZP03LBY]]I
MY_&E*FVK,I55>]]ST3PYJAO3,T18QJ ,CD$U>C\3/;R&-F;Y>J$5FZ+#;^'[
M&.RC0111C@=OQ/K2W]C'JF=L@AF7G!7BN>46MC6\=V:K:^&(*G(/4*>,USWB
M#6W\HJIP<XR.U5[6WG@G$-S&589*MR0:=>QQS1#<BEL^G>N65[BNK71R;2,]
M]%YQ(#.-Q/85Z=:^)M/M(I;82QRF,#RB&&3[&N$N;+?XDT^W(!4J"5."#BN^
MAMXK= D4:1H. J* !^5>IA,,Z\>:]CR\3C/JTE'EN5].DFG5YYHO)+L=J'J!
M[U<[TM%?14X*G%11\S5J.M-U);L2D(I32&K,QII#S2TAH 3J*8:=2$4 --(3
M2DTTFD,:::>:>3ZU&32$,;FHS3V-1DT#&,*:>*5C33S0 UCQ435(U1-0!&U1
M-4K=:B?B@")NM%##-% %G-)GFBDI@/4T\&HEJ5:0$JTX4P=*>* %H/2BB@ S
MS3U.:C%.6@"8'BGBH@:D7H* '9I:2@T[@*#3U[5&.M2+TI@/ZTM(*=0(S-5\
M.:5KNS^TM+LM1*<*;NW27;]-P.*\(^,'A73/"/B?3KC3;"&QM;Q&$L4"[4+Y
MZ@#@=1TQ7T417E7[0^CM=^#H=0C!+V$ZNQ'4(W!_7%<V(@I4V=>&FXU(ZZ'E
MVAQ0QVSV[;?,^UH,$]5)K7U;Q!:Z5-(9[E8V+8V,>F/8UQD6L%&2:/YA*BD=
M\,M>J:MI^E^)-$LKV6&.2.Y4+)O4'#5\]%\KU/I&G)61P5OXBM-0NA'YFTMQ
M@,/TK9T;2%>_?S(O-# #++P1Z_K7+>*/A>=-S-H]U]E4'<%8;E]>AJ+2])^(
M4:I]EO=-D4?=\Z%CD?G77&S7NE0I3D['O.B^"=T;?9H00JXRR]\^M=?86$MG
M (Y8& !R&W?(:\8TW5_B59I!')>V!R0) BG[O? QUK1UG1/$VMPQ[-8O8& /
MF;6]?0*/YT)2.KZO)M)IGJ>I:TD:2AQ&"!C##KBN;/C:*.]6/)DRVQRH9@"0
M.N <5QGAWX.H;B.34]5U#59,Y*3W!VGV(! _"O=M \.6FD:5%;QP1H ,1H$&
M%KGG[KL.I24%N9-E<QZC$BQH_'.\J1QCJ#5"259G?*L4AW/D]CG K5\0:BFB
MVSK$-US*?+4*,EB:PM7E?2=*CC9MLTJ^9*&ZJHZ _7^M<,_>=R(^[&PS12+_
M ,6&4=((MI&:[=37%^!XV\QIF!W2 DEASGK79YKZ3 )*CH?+9@[UOD.%!Z4@
M-+7HGFC6I*4YI*!B<4UA3R*;0,:32'FE[TAH$--)CBG$4TTAC343'%2-P*A8
MTAC6/-0L<U(QYJ,T --(>E*:0T ,;FHFJ5N!43F@"-C43U(W2HG.: (VHI&.
M#12 GS29HHJP' U(IJ YXQ4RGBD!*IQ3P:B!I^:0#Q2DTW-&: %QFG*<&FBE
M'6@"0&I5-0 YIZG% $P/-!IH.:4F@!:>#BF"G TQ$H-.!IBG%/ S0,7.:J:K
MIL&KZ=<V5R@DM[B-HW4]P1BK=!I[AL?'GBSPE=>#-=N-'N VS=YEI-CAU[?X
M&KGAKQ7)#ID^D719</YL.?7N*]E_:"T$:GX(:_C4?:=/D696']WHWZ5X*8(M
M8TD743;;F,<X]17@XBDJ<[=#Z'#574A?JCO4NOM,"HQ)60=Z2PU:]T6:+,9F
MM0<93DJ/>LSP5?F^TY0R_-&V&V]1]:]-TWPO%<0+.)@B$Y)(Z5Q\SB['J1;=
MG%B:7XZ"JCQ1K*K?['/ZUU5EXVEO;06T=NZ,01\L0!_,54MO -O?S0F"^*D$
MY/E _P F&:[W3_!]O80*3<&7!_ACVC^9KHYYM:&\IR^UOZ&9H&CM$5FF'S$9
MVGM6YJEV;"T:=\@XQ5N.QACA9H)N0?\ EHN17+^*+YKB2*U1\F1@,#C [UQ2
M;6YGS7=V1^'K&35+XZK=C]U'GR$)Z#UKE-29]>U663!\C?N;@Y(!PBCZGFNJ
M\2:I'HOA_9%Q*XVC YQTX_"LWPU9,MD)63]]-]Q/0D<D_05FNY,GT)X-%O)O
M#FJ0VEPUO?&U9HY8NJ2'[N/RKY*^%G[=FHZ3XFN/#?Q!M%F^S7#6TNH6R;98
MB&QN=.C#W'/UK[ET2P\NRNI"" Q"+GT':ORZ_;9^&,WPY_:"_MFVMR-(U\"X
M5@/E$AXD7V.>?QK[;"T'' TYM=_Q9\3C*JEC)Q3[?@C],M)U>SUW3;?4-/N8
M[NSN$$D4\3;E=3T(-7,YKX'_ &/_ ([R>!_$L/@S6;AAH6IR8M'E;BVG/0<]
M%;I]<>M?>N:35F9IW'YS1Q30:6I&%)TI:3I0,::2E-%(!AIM/-,/% R-^E0N
M:DD-0L:0QAIA.:>::30 VD-+2&@"-ZB8U(YJ%SUH C8U&QI[&H6- #'.:*1S
MS10!/G%.J,-3@:H!XIPI@.*>*0#U-/!J,&G@T@'@T \T@Y%&: %S3@:9FE4T
M 2 T]340-/7M0!*#3LU&.M.!H >*<.M-4XI0: ) U/#5"&I=],"?=BD+5!).
ML2,[,%51DLQP *^?OC?^V+X8^&MM-8Z)-#XBU\J0L=O(&@A/J[CKCT'Z4$LW
MOVEOC'HW@#PM_8LK)=ZSK!%O#9JWS*I/,C#L!^M?.^D:S/I<^T?-&_52>*^>
MM.\9:K\0OC)I6IZY=M>WM[>J79^@Y^Z!V ["O=M18VM[<6Y/SI(0M<N*HMP5
M7I>QZ6"J:RAUW.Q\)^)?[.UDQA@D4_J,CZ5[CH_B+RK8EV4P?PXYR#Z?G7RH
MLOG' )1\Y!SWKO?"WQ#:RMA:WX!50-LI!/?H:\J5*^QZM.LX;GUGX>UZW$*.
MK[#TX.<'Z5T<GBE6MBCKDXR#ZU\PV'Q'T^!MZW"ACV4D[OQ]:Z&T^*$$@54\
MSL1D$G/T%0H21UO$0DM=SW5=7DDAW'Y(\]R.?Z5QEWJBOJ[S2G='$"<J.,^E
M<R_C*ZO;;;!;F*-AR\Y*D?0=:339OM1,;L=F>3_>:LI1?4SYKO0W)K>Y\5ZF
MFYRL)<#D<*OK7>6-IN>!(!R?DC![C_$GK]#61H6GHD" !D+9+'OC_$]!7IO@
M_15MX/[0E0%F&V)>RCID?AQFNC!X5XNJH=%N<^,Q*PM)S>_0<VG?8+*.W)W,
M!\Q_O'N:^7?VY?"MGK/PI:[EC0W5E=1M"Y'(SP:^L[N(LQ_NCA3[U\@_M\:T
MMCX/TG2PVUKR[+E0>=JC_$U^E)1A2Y5LD?GMW.IS/=L_/77$V.I1B)%.0RG&
M#[5]R_LD?M.CQW86OA'Q1<@>(K=-EK=R'_C]0#@$_P#/0#\_KFOB365$K$;2
M,# YK.MI9]+NH+NSGDMKJ!Q)%+&2K*P.00:^>DKGKH_8\/3@>*^:_P!G_P#:
MUT3QKHEKIOBW4+?2/$40$1EN&V177^V&Z GN#7T9#<QSQ++&ZR1N,JZ'((]0
M:YVK&FY8S1FF!@: U(H<::3FC<"*0T@$8U&QIS5$U(8UC41I[&F$T ,/)III
MQIK&@!I-,9J4GBF,: &,:B8X%2.:A;K0 PU$:E;I4+&@!C44C>]% $HI148:
MG@U0$@-/!J,-Q2AJ0$H-.!XJ,&GCF@!P;BE!IF:6@!^?SI0:8#2%J )E-2"J
MP?%2AZ0$P:G!JAWT>90!8#4%\5RWC+XC>'/A]IK7WB'6+72X .//?YW]E0?,
MQ]@*^6?B3^W_ !1F6U\%:.9>H6_U$8'U6,?U-.PKGV+J.JVFD64MY?74-G:Q
M#<\\[A$4>Y/ KYO^*O[=7A+PB)K3PU$WB74%R!*N4MU/^]U;\!7Q'X^^+/BW
MXF71F\1:U=7R!LK;ERL,?^Z@X'Y5QA4N<#G-,5SU#XE_M'>._BZSQ:QJ\D&E
MELKIUD/*@_$#E_\ @1->;.W&>M.VB) !VJ-CG'K56)-[X4Q?:/B[X8C/_/TI
M-?6/Q%T%H+E-1C7,<H ? ^ZPZ5\N_!*T:?XR:"0"?+8R'VP*^]YM"BUG3Y;2
MX!,$R\XZYKWL'A8XK#3I2Z_F<D\0\/6C470\ "[]I'#'CZ&KMKOMY5\Q/,4]
MNM7=7\,77A[4I+6X#+M.8Y".)$['^E/MT)<*0<CO7QU:C/#U'2J+5'U=.<:T
M%4ALSL_"J:9<H$DLHI';'+1#\^E>FZ98Z=;Q+Y-M%&P'55 __77F?AR+8%*L
M",]#WKT;2F(C0G@#L:X7%MG9%I+8TS"K2<+@>F*U="TY&F9F0G'08/-%O:M,
M%/E@9'I7;^ _!$^K7.%9H8%_UKCM_LCW-5"E*LU2IK5A.I"C%U:CLD;?P_\
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MI63W*(96+$ <9[5V7@Z%0C,PQ@'G%<8.9%_G7<^%AMM),X&1TJZ>Y,MC[8\
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M?#OAB#XA_$#PGH$!=A+<[[M'4;0J\\>HQZU@Z"IAC2Y+";Y@Q5FW!C[U[_\
ML=:#;^+?C!XCU^"Q=;:RM@D"D#$<CGY@,=L9Q7JQ7-RQ9RSERQ;1]P>&_!NF
MZGH+V!A06^!&%V\8  Q7D7BO]FVYT/Q(-8\,SMINH1OOBGMVV,I_#^1KZ/\
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MB:#6I*&-)GBD AZ44E% &/NS3@:B)H#5J!,#BI%:JX:GAJ +(:G XJ /3@U
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M)2MZ&WB4 9!]A4WB.3R?$EK((DD*\JLJAE./4'BI=.OULKTWSV\=Q(^=L;J
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M+;'T/KTJK!'M"CMBKB$@@ 9X[FD@"4\;<X8BI()Y$@1/+&X 9R>II!DR \<
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M$Q'<Q.3WJP@)<$9/O1&IV@8R:EA3DX.*=K:"N.0[<#H2*E#@MC(],&D"%2I
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'*C+45(S_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>plx-20220629.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.8119.21675 -->
<!--Based on XBRL 2.1-->
<!--Created on: 6/30/2022 8:42:01 PM-->
<!--Modified on: 6/30/2022 8:42:01 PM-->
<xsd:schema targetNamespace="http://protalix.com/20220629" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:srt-roles="http://fasb.org/srt-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:attributeFormDefault="unqualified" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:plx="http://protalix.com/20220629" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:net="http://www.xbrl.org/2009/role/net">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://protalix.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="plx-20220629_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="plx-20220629_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
  <xsd:element name="DocumentAndEntityInformationAbstract" id="plx_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>plx-20220629_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.8119.21675 -->
<!--Based on XBRL 2.1-->
<!--Created on: 6/30/2022 8:42:01 PM-->
<!--Modified on: 6/30/2022 8:42:01 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink">
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="plx-20220629.xsd#plx_DocumentAndEntityInformationAbstract" xlink:label="plx_DocumentAndEntityInformationAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="plx_DocumentAndEntityInformationAbstract" xlink:to="plx_DocumentAndEntityInformationAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="plx_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Adress Line Two</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, State or Province</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Written Communications</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Soliciting Material</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Issuer Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>plx-20220629_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.8119.21675 -->
<!--Based on XBRL 2.1-->
<!--Created on: 6/30/2022 8:42:01 PM-->
<!--Modified on: 6/30/2022 8:42:01 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="plx-20220629.xsd#DocumentDocumentAndEntityInformation" roleURI="http://protalix.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://protalix.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="plx-20220629.xsd#plx_DocumentAndEntityInformationAbstract" xlink:label="plx_DocumentAndEntityInformationAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType_637922185212434526" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="plx_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentType_637922185212434526" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_637922185212434526" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="plx_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentPeriodEndDate_637922185212434526" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_637922185212434526" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="plx_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityFileNumber_637922185212434526" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_637922185212434526" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="plx_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityRegistrantName_637922185212434526" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_637922185212444706" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="plx_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_637922185212444706" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_637922185212444706" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="plx_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityTaxIdentificationNumber_637922185212444706" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_637922185212444706" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="plx_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressAddressLine1_637922185212444706" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2_637922185212444706" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="plx_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressAddressLine2_637922185212444706" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_637922185212444706" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="plx_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressStateOrProvince_637922185212444706" order="9" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_637922185212444706" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="plx_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressCityOrTown_637922185212444706" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_637922185212444706" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="plx_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressPostalZipCode_637922185212444706" order="11" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_637922185212444706" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="plx_DocumentAndEntityInformationAbstract" xlink:to="dei_CityAreaCode_637922185212444706" order="12" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_637922185212444706" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="plx_DocumentAndEntityInformationAbstract" xlink:to="dei_LocalPhoneNumber_637922185212444706" order="13" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications_637922185212454662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="plx_DocumentAndEntityInformationAbstract" xlink:to="dei_WrittenCommunications_637922185212454662" order="14" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial_637922185212454662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="plx_DocumentAndEntityInformationAbstract" xlink:to="dei_SolicitingMaterial_637922185212454662" order="15" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer_637922185212454662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="plx_DocumentAndEntityInformationAbstract" xlink:to="dei_PreCommencementTenderOffer_637922185212454662" order="16" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer_637922185212454662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="plx_DocumentAndEntityInformationAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer_637922185212454662" order="17" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_637922185212454662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="plx_DocumentAndEntityInformationAbstract" xlink:to="dei_Security12bTitle_637922185212454662" order="18" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_637922185212454662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="plx_DocumentAndEntityInformationAbstract" xlink:to="dei_TradingSymbol_637922185212454662" order="19" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_637922185212454662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="plx_DocumentAndEntityInformationAbstract" xlink:to="dei_SecurityExchangeName_637922185212454662" order="20" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_637922185212454662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="plx_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityEmergingGrowthCompany_637922185212454662" order="21" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_637922185212454662" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="plx_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCentralIndexKey_637922185212454662" order="22" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_637922185212464555" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="plx_DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentFlag_637922185212464555" order="23" use="optional" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140317320280416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 29, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_plx_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 29,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Protalix BioTherapeutics,&#160;Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">65-0643773<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2 University Plaza<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Adress Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Hackensack<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07601<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">696-9345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PLX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001006281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_plx_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">plx_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>plx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>plx-20220629x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="plx-20220629.xsd" xlink:type="simple"/>
    <context id="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001006281</identifier>
        </entity>
        <period>
            <startDate>2022-06-29</startDate>
            <endDate>2022-06-29</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg"
      id="Tc__Yj22le_BUegyw6X7dj_RQ_2_1">0001006281</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg"
      id="Tc_xT_Rm3hJ5kSCd_lo8HvBug_3_1">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg"
      id="Narr_1W7FGdRXS0aT_Abpo1tvJA">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg"
      id="Narr_qLZDCZoOLE6-2mkJUSdMeQ">2022-06-29</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg"
      id="Narr_MUUPBGJ8pU-9e0KOAp7UXg">Protalix BioTherapeutics,&#160;Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg"
      id="Tc_CA84kJMf0kqwPT-wjJQG4g_1_0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg"
      id="Tc_dEbe0TfPg0Sg8Hs2sloUyQ_1_2">001-33357</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg"
      id="Tc_Nl-g9ajxPkepSU6oZyT0kQ_1_4">65-0643773</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg"
      id="Tc_t7nSyw6twkquMb7bU8WWZA_4_0">2 University Plaza</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg"
      id="Tc_WAKgzDpNSEmoGVS8X329mg_5_0">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg"
      id="Narr_PQ9n9lw3LU2FzCOZZvmkDQ">Hackensack</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg"
      id="Narr_QL8QrMygXk2Lx7l-rUQRSw">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg"
      id="Tc_d8ZYb8g62ECfUMEsaI6vCw_6_4">07601</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg"
      id="Narr_FO8gwj9XgUyaUtsymSwdyg">201</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg"
      id="Narr_bOQGoZ7wNkuc9wH5CEkWzA">696-9345</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg"
      id="Narr_9oAL9kf_OUGtCuF8BiWhaQ">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg"
      id="Narr_siaT9q8PZUCy6jndT-dvIw">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg"
      id="Narr_K5ps0hLs10GyP_44f_6-rg">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg"
      id="Narr_W-3meAowz0OzE3lcnC0R2A">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg"
      id="Tc_aW3-ssdNBE6PWV9sgN6lLw_2_0">Common stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg"
      id="Tc_f-j9iEEAlUOcuYzFxJbtDA_2_1">PLX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg"
      id="Tc_3CqIg8mhREKkATw7m76Qxg_2_2">NYSEAMER</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg"
      id="Narr_lmGOFGRG3EutpwYxjUYdcg">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MTG1X#SY['R73>RHY_U=3_ 102P,$%     @ 1(G>5)>*NQS     $P(   L
M  !?<F5L<R\N<F5L<YV2N6[#, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2!8I%
MG;^OVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XU
MA]) 1-MC0[!:+#Y +AEFM[UD%J=SI%>(7->=I3W;+T]!;X"O.DQQ0FE(2S,.
M\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'<?VD-/IKV,B
MM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " !$B=Y4'#AEZC\!
M   \ @  #P   'AL+W=O<FMB;V]K+GAM;(U1RV["0 S\E=5^0!-0BU1$N)0^
MD*H6E8K[DG6(Q3XBKP,M7U\G452D7GKR>FR-9V87YTC'?8Q']>5=2(6NF9MY
MEJ6R!F_236P@R*2*Y U+2X<L-03&IAJ O<NF>3[+O,&@EXN1:T/9=1,92L88
M!.R '<(Y_<Z[5ITPX1X=\G>A^[<#K3P&]'@!6^A<JU3'\TLDO,3 QFU+BLX5
M>C(,=D",Y1]XVXG\-/O4(VSV'T:$%'J6"V&%E+C?Z/F-:#R!+ ]=R_$)'0.M
M#,,SQ;;!<.AHQ$5V9://8:Q#B'/Z3XRQJK"$52Q;#X&'' E<)S"D&IND53 >
M"CVN*!.L>@PL(:EU&*ADMW,JI]=V<,TB]RI#FJ,,:&T'X:-:"Q4&L&]R( DN
MR94;4EWI>::W=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%     @ 1(G>5"0>
MFZ*M    ^ $  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<[61/0Z#
M, R%KQ+E #50J4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_OR4Z?:!1W
M;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9
MHIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJ
MEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    ( $2)
MWE1ED'F2&0$  ,\#   3    6T-O;G1E;G1?5'EP97-=+GAM;*V334[#,!"%
MKQ)E6R4N+%B@IAM@"UUP 6-/&JO^DV=:TMLS3MI*H!(5A4VL>-Z\SYZ7K-Z/
M$;#HG?78E!U1?!0"50=.8ATB>*ZT(3E)_)JV(DJUDUL0]\OE@U#!$WBJ*'N4
MZ]4SM')OJ7CI>1M-\$V9P&)9/(W"S&I*&:,U2A+7Q<'K'Y3J1*BY<]!@9R(N
M6%"*JX1<^1UPZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!ZVN+*&4/;&@4ZJ+WCEAIC
M JFQ R!GZ]%T,4TFGC",S[O9_,%F"LC*30H1.;$$?\>=(\G=560C2&2FKW@A
MLO7L^T%.6X.^D<WC_0QI-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_
M7G\!4$L! A0#%     @ 1(G>5 =!36*!    L0   !               ( !
M     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !$B=Y4(L<M0^X    K
M @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M    " !$B=Y4F5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE
M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( $2)WE1$S*X.:@0  %<1   8
M          " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " !$B=Y4GZ ;\+$"  #B#   #0              @ &M#   >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( $2)WE27BKL<P    !,"   +
M  "  8D/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( $2)WE0<.&7J/P$  #P"
M   /              "  7(0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M" !$B=Y4)!Z;HJT   #X 0  &@              @ '>$0  >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !$B=Y499!YDAD!  #/ P
M$P              @ '#$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
.."0 ) #X"   -%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="plx-20220629x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protalix.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="plx-20220629x8k.htm">plx-20220629x8k.htm</File>
    <File>plx-20220629.xsd</File>
    <File>plx-20220629_lab.xml</File>
    <File>plx-20220629_pre.xml</File>
    <File>plx-20220629xex99d1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "plx-20220629x8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "plx-20220629x8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "plx-20220629_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "plx-20220629_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "plx-20220629.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "plx",
   "nsuri": "http://protalix.com/20220629",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "plx-20220629x8k.htm",
      "contextRef": "Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00090 - Document - Document and Entity Information",
     "role": "http://protalix.com/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "plx-20220629x8k.htm",
      "contextRef": "Duration_6_29_2022_To_6_29_2022_1t_xgqm6j0iqksScFyFUZg",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://protalix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://protalix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://protalix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://protalix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://protalix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Adress Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://protalix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://protalix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://protalix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://protalix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://protalix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://protalix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://protalix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://protalix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://protalix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://protalix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://protalix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://protalix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://protalix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://protalix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://protalix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://protalix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://protalix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://protalix.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "plx_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document and Entity Information [Abstract]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://protalix.com/20220629",
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001558370-22-010491-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001558370-22-010491-xbrl.zip
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M/&V)9Q,FW2J$J(<8IN+("3Z*TVE)R*+N K!21BORE1,9#IJZUK.)2VS%LA:
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MA6KM!M)N&Z4;>S-R5VS)GWRGN]+>=_\!4$L#!!0    ( $2)WE2>J:S,GP0
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MIG_UU,M,#@FD71KUX@CWC:408<^RUNMU8]UL,+Z0_6W'^C9^?O.6*( FII&
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M?H =8S@4JQ\D 49C;T8PLQP8":%8.@@\[/AUUVOA # +G4KII*@F%2G6SVP
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M>.]M@*=K1E? 85YP#%KE"QUG4LPD92UZ;_1L.$QS3M/H270=?>1@#%017(>
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M,C(P-C(Y+GAS9%!+ 0(4 Q0    ( $2)WE0#O"J5H04  .4^   4
M      "  ? #  !P;'@M,C R,C V,CE?;&%B+GAM;%!+ 0(4 Q0    ( $2)
MWE2>J:S,GP0  $8J   4              "  <,)  !P;'@M,C R,C V,CE?
M<')E+GAM;%!+ 0(4 Q0    ( $2)WE08KH,!"AT  $,- 0 3
M  "  90.  !P;'@M,C R,C V,CEX.&LN:'1M4$L! A0#%     @ 1(G>5,0@
M(WZ/#   H20  !<              ( !SRL  '!L>"TR,#(R,#8R.7AE>#DY
<9#$N:'1M4$L%!@     %  4 2 $  ),X      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
